Analgesics (Pharmacies) - Sudan

  • Sudan
  • Revenue in the Analgesics market is projected to reach US$35.07m in 2024.
  • Revenue is expected to show an annual growth rate (CAGR 2024-2029) of 6.04%, resulting in a market volume of US$47.03m by 2029.
  • In global comparison, most revenue will be generated in China (US$5,028.00m in 2024).
  • In relation to total population figures, per person revenues of US$0.71 are generated in 2024.

Key regions: China, South Korea, Canada, India, France

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The Analgesics (Pharmacies) market in Sudan is witnessing significant growth and development in recent years.

Customer preferences:
Customers in Sudan have shown a growing preference for analgesics purchased from pharmacies. This is due to the convenience and accessibility of pharmacies, which are widely spread across the country. Additionally, customers tend to trust pharmacies more than other channels, such as supermarkets or online platforms, when it comes to purchasing healthcare products like analgesics.

Trends in the market:
One of the key trends in the Analgesics (Pharmacies) market in Sudan is the increasing demand for over-the-counter (OTC) analgesics. Customers are increasingly seeking self-medication options for common ailments such as headaches, muscle pain, and fever. This trend is driven by the rising awareness about the effectiveness and safety of OTC analgesics, as well as the affordability of these products compared to prescription medications. Another trend in the market is the growing popularity of herbal and natural analgesics. Sudan has a rich tradition of herbal medicine, and customers are increasingly seeking natural alternatives to conventional analgesics. This trend is also influenced by the global shift towards natural and organic products in the healthcare industry.

Local special circumstances:
Sudan has a high prevalence of certain health conditions that contribute to the demand for analgesics. For example, the country has a high incidence of malaria, which often leads to symptoms such as fever and body aches. This drives the demand for analgesics that can provide relief from these symptoms. Additionally, Sudan has a hot climate, which can contribute to conditions such as dehydration and headaches, further driving the demand for analgesics.

Underlying macroeconomic factors:
The growing Analgesics (Pharmacies) market in Sudan can be attributed to several underlying macroeconomic factors. Firstly, the country has experienced stable economic growth in recent years, which has led to an increase in disposable income and improved living standards. This has allowed more people to afford healthcare products, including analgesics. Furthermore, the government of Sudan has been investing in the healthcare sector, including the expansion of healthcare infrastructure and the improvement of healthcare services. This has contributed to the overall growth of the pharmaceutical market, including the Analgesics (Pharmacies) segment. In conclusion, the Analgesics (Pharmacies) market in Sudan is witnessing growth and development due to customer preferences for pharmacy purchases, the increasing demand for OTC analgesics, the popularity of herbal and natural alternatives, local health conditions, and underlying macroeconomic factors such as economic growth and government investment in healthcare.

Methodology

Data coverage:

The data encompasses B2C enterprises. Figures are based on offline and online spending by consumers, including VAT. Not included are B2B and B2G sales, or other pharmaceutical sales through hospitals or retail stores such as supermarkets.

Modeling approach:

Market sizes are determined through a bottom-up approach, building on specific predefined factors for each market market. As a basis for evaluating markets, we use industry associations, third-party studies and reports and survey results from our primary research (e.g., the Statista Global Consumer Survey). In addition, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per country, consumer healthcare spending, GDP and internet penetration. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the relevant market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. For forecasting digital trends such as the online-pharmacy sales share we use exponential trend smoothing and the s-curve method. The main drivers are healthcare expenditure per country and consumer healthcare spending.

Additional notes:

The data is modeled using current exchange rates. The impact of the COVID-19 pandemic and the Russia-Ukraine war are considered at a country-specific level. The market is updated twice a year. GCS data is reweighted for representativeness.

Overview

  • Revenue
  • Analyst Opinion
  • Global Comparison
  • Methodology
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Ayana Mizuno
Ayana Mizuno
Junior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)